BIOMAT Database Logo BIOMAT Database Logo

Kidney transplantation from anti-HCV-positive donors to anti-HCV-positive recipients. 1993

E Velidedeoğlu, and H Simşek, and M Haberal
Turkish Transplantation and Burn Foundation Hospital, Ankara.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D008111 Liver Function Tests Blood tests that are used to evaluate how well a patient's liver is working and also to help diagnose liver conditions. Function Test, Liver,Function Tests, Liver,Liver Function Test,Test, Liver Function,Tests, Liver Function
D002102 Cadaver A dead body, usually a human body. Corpse,Cadavers,Corpses
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D006508 Hepatitis Antibodies Immunoglobulins raised by any form of viral hepatitis; some of these antibodies are used to diagnose the specific kind of hepatitis. Antibodies, Hepatitis
D006526 Hepatitis C INFLAMMATION of the LIVER in humans caused by HEPATITIS C VIRUS, a single-stranded RNA virus. Its incubation period is 30-90 days. Hepatitis C is transmitted primarily by contaminated blood parenterally and is often associated with transfusion and intravenous drug abuse. However, in a significant number of cases, the source of hepatitis C infection is unknown. Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted,Parenterally-Transmitted Non-A, Non-B Hepatitis,PT-NANBH,Parenterally Transmitted Non A, Non B Hepatitis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D016030 Kidney Transplantation The transference of a kidney from one human or animal to another. Grafting, Kidney,Renal Transplantation,Transplantation, Kidney,Transplantation, Renal,Kidney Grafting,Kidney Transplantations,Renal Transplantations,Transplantations, Kidney,Transplantations, Renal
D016174 Hepacivirus A genus of FLAVIVIRIDAE causing parenterally-transmitted HEPATITIS C which is associated with transfusions and drug abuse. Hepatitis C virus is the type species. Hepatitis C virus,Hepatitis C-Like Viruses,Hepaciviruses,Hepatitis C Like Viruses,Hepatitis C viruses,Hepatitis C-Like Virus
D018937 Hepatitis C Antibodies Antibodies to the HEPATITIS C ANTIGENS including antibodies to envelope, core, and non-structural proteins. Anti-HCV Antibodies,Anti-Hepatitis C Virus Antibodies,HCV Antibodies,Hepatitis C Virus Antibodies,Anti HCV Antibodies,Anti Hepatitis C Virus Antibodies

Related Publications

E Velidedeoğlu, and H Simşek, and M Haberal
Transplantation of kidneys from Anti-HCV positive donors.
January 2001, Transplantation proceedings,
E Velidedeoğlu, and H Simşek, and M Haberal
Dilemmas of organ transplantation from anti-HCV-positive donors.
February 1995, Lancet (London, England),
E Velidedeoğlu, and H Simşek, and M Haberal
A review of kidney transplantation from HCV-viremic donors into HCV-negative recipients.
December 2021, Kidney international,
E Velidedeoğlu, and H Simşek, and M Haberal
Long-term results of kidney transplantation from HCV-positive donors.
November 2007, Transplantation proceedings,
E Velidedeoğlu, and H Simşek, and M Haberal
Sofosbuvir/Velpatasvir Prophylaxis for 12 Weeks in Hepatitis C Virus (HCV)-Negative Recipients Receiving Kidney Transplantation from HCV-Positive Donors.
September 2021, Annals of transplantation,
E Velidedeoğlu, and H Simşek, and M Haberal
[Hepatitis C virus (HCV) status in recipients transfused with blood from anti-HCV-positive donors].
March 1998, Ugeskrift for laeger,
E Velidedeoğlu, and H Simşek, and M Haberal
Outcomes following liver transplantation from HCV-seropositive donors to HCV-seronegative recipients.
April 2021, Journal of hepatology,
E Velidedeoğlu, and H Simşek, and M Haberal
Kidney transplantation from hepatitis B (HB)-positive donors to HB negative recipients: anti-HB Core immunoglobulin G became positive in all recipients after the transplantation.
April 2013, Transplantation proceedings,
E Velidedeoğlu, and H Simşek, and M Haberal
Liver transplantation from old donors into HCV and non-HCV recipients.
April 2004, Transplantation proceedings,
E Velidedeoğlu, and H Simşek, and M Haberal
Hepatitis C virus (HCV) RNA among anti-HCV-positive blood donors and their recipients.
January 1993, Vox sanguinis,
Copied contents to your clipboard!